Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis

Japanese Journal of Cancer Research

Volumn 90, Issue 6, 1999, Pages 647-654

  Tanaka, Katsuhiro ^a   Abe, Mayumi ^a   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; bFGF; ERK1 2; p38 MAP kinase

Indexed keywords

ACTIN; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN GEL; ENZYME INHIBITOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; VINCULIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032815701     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00796.x     Document Type: Article

References (42)

1. Fidler, I. J. and Ellis, L. M. The implications of angiogenesis for the biology and the therapy of cancer metastasis. Cell, 79, 185-188 (1994).
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1, 27-31 (1995).
3. Holmgren, L., O'Reilly, M. S. and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1, 149-153 (1995).
4. Folkman, J. and Shing, Y. Angiogenesis. J. Biol. Chem., 267, 10931-10934 (1992).
5. Zagzag, D. Angiogenic growth factors in neural embryogenesis and neoplasia. Am. J. Pathol., 146, 293-309 (1995).
6. Ferrara, N. and Davis-Smith, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18, 4-25 (1997).
7. Mustonen, T. and Alitalo, K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol., 129, 895-898 (1995).
8. Rifkin, D. B. and Moscatelli, D. Recent development in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109, 1-6 (1989).
9. Hori, A., Sasada, R., Matsunami, E., Naito, K., Sakura, Y., Fujita, T. and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51, 6180-6184 (1991).
10. Brem, S., Tsanaclis, A. M., Gately, S., Gross, J. L. and Herblin, W. F. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer, 70, 2673-2680 (1992).
11. Iwasaka, C., Tanaka, K., Abe, M. and Sato, Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metaloproteinase-1 and the migration of vascular endothelial cells. J. Cell. Physiol., 169, 522-531 (1996).
12. Waskiewicz, A. J. and Cooper, J. A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol., 7, 798-805 (1995).
13. Force, T., Pombo, C. M., Avruch, J. A., Bonventre, J. V. and Kyriakis, J. M. Stress-activated protein kinases in cardiovascular disease. Circ. Res., 78, 947-953 (1996).
14. Pages, G., Lenormand, P., L'Allemain, G., Chambard, J.-C., Meloche, S. and Pouyssegur, J. Mitogen-activating protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA, 90, 8319-8323 (1993).
15. Gardner, A. M. and Johnson, G. L. Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated kinase. J. Biol Chem., 271, 14560-14566 (1996).
16. Rousseau, S., Houle, F., Landry, J. and Huot, J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene, 15, 2169-2177 (1997).
17. Hibi, M., Lin, A., Smeal, T., Minden, T. and Karin, M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7, 2135-2148(1993).
18. Yanai, N., Satoh, T. and Obinata, M. Endothelial cells create a hematopoietic inductive microenvironment preferential to erythropoiesis in the mouse spleen. Cell Struct. Funct., 16, 87-93 (1991).
19. Tanaka, K., Oda, N., Iwasaka, C., Abe, M. and Sato, Y. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J. Cell. Physiol., 176, 235-244 (1998).
20. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiei, A. R. PD098059 is a specific inhibitor of the activation of mitogen activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494 (1995).
21. Cuenda, A., Rouse, J., Doza, Y. N., Meiser, R., Cohen, P., Gallagher, T. F., Young, P. R. and Lee, J. C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett., 364, 229-233 (1995).
22. Lauffenburger, D. A. and Horwitz, A. F. Cell migration: a physically integrated molecular process. Cell, 84, 359-369 (1996).
23. Cook, S. J. and McCormick, F. Kinetic and biochemical correlation between sustained p44ERK1 (44kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem. J., 320, 237-245 (1996).
24. Weber, J. D., Raben, D. M., Phillips, P. J. and Baldassare, J. J. Sustained activation of extracellular signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J., 326, 61-68 (1997).
25. Crawley, J. B., Rawlinson, L., Lali, F. V., Page, T. H., Saklatvala, J. and Foxwell, B. M. J. T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J. Biol. Chem., 272, 15023-15027 (1997).
26. Craxton, A., Shu, G., Graves, J. D., Saklatvala, J., Krebs, E. G. and Clark, E. A. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocyte. J. Immunol., 161, 3225-3236 (1998).
27. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B. and Davis, R. J. MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol., 16, 1247-1255 (1996).
28. Tan, Y., Rouse, J., Zhang, S. C., Cohen, P. and Comb, M. J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J., 15, 4629-4642 (1996).
29. Huot, J., Houle, F., Marceau, F. and Landry, J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res., 80, 383-392 (1997).
30. Guay, J., Lambert, H., Gingras-Breton, G., Lavoie, J. N., Huot, J. and Landry, J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci., 110, 357-368 (1997).
31. Oda, N., Abe, M. and Sato, Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3. J. Cell. Physiol., 178, 121-132 (1999).
32. Fibbi, G., Ziche, M., Morbidelli, L., Magnelli, L. and Rosso, M. D. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp. Cell Res., 179, 385-395 (1988).
33. Odekon, L. E., Sato, Y. and Rifkin, D. B. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Physiol., 150, 258-263 (1992).
34. Leavesley, D. I., Schwartz, M. A., Rosenfeld, M. and Cheresh, A. Integrin β1-and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol., 121, 163-170 (1993).
35. Liaw, L., Lindner, V., Schwartz, S. M., Chambers, A. F. and Giachelli, C. M. Osteopontin and ανβ3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp dependent endothelial migration in vitro. Circ. Res., 77, 665-672 (1995).
36. Jorcyk, C. L., Watson, D. K., Mavrothalassitis, G. J. and Papas, T. S. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene, 6, 523-532 (1991).
37. Majerus, M. A., Bibollet-Ruche, F., Telliez, J. B., Wasylyk, B. and Bailleul, B. Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter. Nucleic Acids Rex., 20, 2699-2703 (1992).
38. Slupsky, C. M., Gentile, L. N., Donaldson, L. W., Mackereth, C. D., Seidel, J. J., Graves, B. J. and McIntosh, L. P. Structure of the Ets-1 pointed domain and mitogen-activated proten kinase phosphorylation site. Proc. Natl. Acad. Sci. USA, 95, 12129-12134 (1998).
39. Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J. A., Lin, S. and Han, J. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem., 271, 17920-17926 (1996).
40. Li, Z., Jiang, Y., Ulevitch, R. J. and Han, J. The primary structure of p38γ a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun., 228, 334-340 (1996).
41. Wang, X. S., Diener, K., Manthey, C. L., Wang, S., Rosenzweig, B., Bray, J., Delaney, J., Cole, C. N., Chan-Hui, P. Y., Mantlo, N., Lichenstein, H. S., Zukowski, M. and Yao, Z. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem., 272, 23668-23674 (1997).
42. Wang, Y., Huang, S., Sah, V. P., Ross, J., Jr., Brown, J. H., Han, J. and Chien, K. R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem., 273, 2161-2168 (1998).